Translational Pathways for Cardiovascular Devices

INTRODUCTION
Meet The Course Directors
3 Topics
Course Director Spencer B. King, MD
Course Director Anthony N. DeMaria, MD
Course Director Nabil Dib, MD, MSC, FACC
Welcome and Introduction
8 Topics
Fulfill Unmet Educational Need (Knowledge Gap)
Translational Pathway for Trans Aortic Valve Replacement-TAVR
FlowFusion ND Infusion Catheter
U.S. Regulatory Device Evaluation
Translational Pathways for Cardiovascular Devices
Translational Pathway for Cardiovascular Therapy
Who should take this course?
Course Sessions
ISCTR Mission
2 Topics
Learning Objectives
Lecture – Nabil Dib, MD, Msc, President of ISCTR
Translational Pathway to Expedite Scientific Discovery to Patients
2 Topics
Learning Objectives
Lecture – Robert Califf, MD, FDA
SESSION I: BASIC KNOWLEDGE FOR CV DEVICES DEVELOPMENT
Session I
Session I: Basic Knowledge for CV Devices Development
Concept/Innovation
3 Topics
Choosing an Innovative Concept
Learning Objectives
Lecture – Todd Brinton, MD, Edward’s Lifesciences
Intellectual Property
3 Topics
Intellectual Property
Learning Objectives
Lecture – James Inskeep, Patent Attorney
Business Plan, Development, and Fundraising
3 Topics
Business Plan, Product Development, and Fundraising
Learning Objectives
Lecture – Stan Rowe, Edward’s Lifesciences
Product Manufacturing
6 Topics
Requirements for Medical Device Manufacturing and Iteration FDA Point of View
Learning Objectives
Lecture – Brad Quinn, FDA
Requirements for Medical Device Manufacturing and Iteration Industry Point of View
Learning Objectives
Lecture – Richard Rapoza, PhD, Abbott Vascular
Preclinical Evaluation
12 Topics
Advanced Cardiac Anatomy – Application in Translational Research Tailored to Current and Future Technology
Learning Objectives
Lecture – Renu Virmani, MD, CV Path Institute
Large Animal Model for Heart Failure, Valvular Disease, Coronary Artery Disease, and Device Testing
Learning Objectives
Lecture – Daniel Burkhoff, MD, Colombia University
Pre-Clinical Study Design and Endpoints for Device Evaluation FDA Point Of View
Learning Objectives
Lecture – Judith Davis, DVM, MS, FDA
Pre-Clinical Study Design and Endpoints for Device Evaluation Investigator Point Of View
Learning Objectives
Lecture – Renu Virmani, MD, CV Path Institute
Early Feasibility Study
6 Topics
Early Feasibility Studies for Device Evaluation
Learning Objectives
Lecture – Andrew Farb, MD, FDA
Current Challenges and Future Direction for Human Early Feasibility Study for Device Evaluation – Industry Point of View
Learning Objectives
Lecture – David Reuter, MD, Seattle Children’s Hospital
Biostatistics
24 Topics
Basic in Statistics
Clinical Study Design for Translational Research – Learning Objectives
Lecture – Chris Mullin, PhD, NAMSA
Basic Statistical Concepts – Learning Objectives
Lecture – Chris Mullin, PhD, NAMSA
Sample Size and Power – Learning Objectives
Lecture – Chris Mullin, PhD, NAMSA
Sensitivity and Specificity – Learning Objectives
Lecture – Chris Mullin, PhD, NAMSA
Common Study Design – Learning Objectives
Lecture – Chris Mullin, PhD, NAMSA
Phases of Translational Research- Learning Objectives
Lecture – Chris Mullin, PhD, NAMSA
Statistics for Evaluation of Cardiovascular Diagnostic Devices – Learning Objectives
Lecture – Chris Mullin, PhD, NAMSA
Pre-Clinical and Clinical Trial Design and Endpoints of Fast Track to Device Approval
Learning Objectives
Lecture – Roseann White, PhD, Duke Research Institute
Advanced Statistical Methods for Translational Research
Learning Objectives
Lecture – Chris Mullin, PhD, NAMSA
Clinical Endpoints/Surrogate Endpoints
Learning Objectives
Lecture – Roseann White, PhD, Duke Research Institute
Regulatory Approval
6 Topics
Regulatory Requirement for Marketing Approval
Learning Objectives
Lecture – Bram Zuckerman, MD, FDA
Regulatory Review of Cardiovascular Devices: European Regulatory Perspective
Learning Objectives
Lecture – Robert Byrne, MD, Heart Centre, Germany
Reimbursement
3 Topics
CMS Criteria for Reimbursement for Cardiovascular Innovation
Learning Objectives
Lecture – Joseph Chin, MD, CMS
Practice Guideline
3 Topics
Practice Guideline Requirement for New Technology
Learning Objectives
Lecture – Alice Jacobs, MD, Boston University
Technology Adoption
6 Topics
Adoption of Technology
Learning Objectives
Lecture – Ian Meredith, MD, Boston Scientific
Global Heart Health, Implications for Translational Research
Learning Objectives
Lecture – Salim Yusuf, D. Phil, World Federation of Cardiology
Patients
3 Topics
The Patients Voice
Learning Objectives
Lecture – Mark Mercola, PhD, Stanford Cardiovascular Institute
Session I: Basic Knowledge for CV Devices Development - End
SESSION II: TRANSLATIONAL PATHWAY FOR TRANSCATHETER AORTIC VALVE
Session II
Session II: Translational Pathway for Transcatheter Aortic Valve
1 Topic
Session II Topics
The Clinical Need for Innovative Treatment for Aortic Valve Disease
2 Topics
Learning Objectives
Lecture – Martin Leon, MD, Columbia University
The Methods for Transcatheter Aortic Valve Development
2 Topics
Learning Objectives
Lecture – Stan Rowe, Edwards’s Lifesciences
The Endpoints for Transcatheter Aortic Valve Development
2 Topics
Learning Objectives
Lecture – Ori Ben-Yehuda, MD, Cardiovascular Research Foundation
Current Challenges and Future Direction for Aortic Valve Development and Iteration - FDA Point of View
2 Topics
Learning Objectives
Lecture – Nicole Ibrahim, PhD, FDA
Current Challenges and Future Direction for Aortic Valve Development and Iteration - Industry Point of View
2 Topics
Learning Objectives
Lecture – Stan Rowe, Edward’s Lifesciences
The TAVR Development from Concept to First in Man
2 Topics
Learning Objectives
Lecture – Alain Cribier, MD, University of Rouen, France
The TAVR Development from First in Man to Phase 3 and Beyond
2 Topics
Learning Objectives
Lecture – Martin Leon, MD, Columbia University
Session II: Translational Pathway for Transcatheter Aortic Valve - End
SESSION III: TRANSLATIONAL PATHWAY FOR TRANSCATHETER MITRAL/TRICUSPID VALVE DEVICES
Session III
Session III: Translational Pathway for Transcatheter Mitral/Tricuspid Valve Devices
1 Topic
Session III Topics
The Clinical Need for Innovative Treatment for Mitral/Tricuspid Valve Disease
2 Topics
Learning Objectives
Lecture – Michael Mack, MD, Baylor Scott & White Health
The Methods for Translational Mitral/Tricuspid Valve Device Development
2 Topics
Learning Objectives
Lecture – Michael Mack, MD, Baylor Scott & White Health
The Endpoints for Transcatheter Mitral/Tricuspid Valve Device Development
2 Topics
Learning Objectives
Lecture – Blasé Carabello, MD, East Carolina University
Current Challenges and Future Direction for Mitral/Tricuspid Valve Device Development and Iteration - FDA Point of View
2 Topics
Learning Objectives
Lecture – John Laschinger, MD, FDA
Current Challenges and Future Direction for Mitral/Tricuspid Valve Device Development and Iteration - Industry Point of View
2 Topics
Learning Objectives
Lecture – Patricia Todd, Edward’s Lifesciences
Session III: Translational Pathway for Transcatheter Mitral/Tricuspid Valve Devices - End
SESSION IV: TRANSLATIONAL PATHWAY FOR CORONARY STENT
Session IV
Session IV: Translational Pathway for Coronary Stent
1 Topic
Session IV Topics
The Clinical Need for Innovative Coronary Stent
2 Topics
Learning Objectives
Lecture – Gregg Stone, MD, Columbia University
The Methods for Coronary Stent Development
2 Topics
Learning Objectives
Lecture – Charles Simonton, MD, Abbott Vascular
The Endpoints for Coronary Stent Development
2 Topics
Learning Objectives
Lecture – Donald Cutlip, MD, Beth Israel-Deaconess
Current Challenges and Future Direction for Coronary Stent Development and Iteration - FDA Point of View
2 Topics
Learning Objectives
Lecture – Michael John, MPH, FDA
Current Challenges and Future Direction for Coronary Stent Development and Iteration - Industry Point of View
2 Topics
Learning Objectives
Lecture – Charles Simonton, MD, Abbott Vascular
Session IV: Translational Pathway for Coronary Stent - End
SESSION V: TRANSLATIONAL PATHWAY FOR CATHETER ABLATION
Session V
Session V: Translational Pathway for Catheter Ablation
1 Topic
Session V Topics
The Clinical Need for the Treatment of Arrhythmia Innovative Catheter Ablation  
2 Topics
Learning Objectives
Lecture – Douglas Packer, MD, Mayo Clinic
Methods for Catheter Ablation Development
2 Topics
Learning Objectives
Lecture – Douglas Packer, MD, Mayo Clinic
The Endpoints for Catheter Ablation Development
2 Topics
Learning Objectives
Lecture – Marco Cannella, PhD, FDA
Current Challenges and Future Direction for Catheter Ablation Development and Iteration - FDA Point of View  
2 Topics
Learning Objectives
Lecture – Mark Fellman, MS, FDA
Current Challenges and Future Direction for Catheter Ablation Development and Iteration - Industry Point of View  
2 Topics
Learning Objectives
Lecture – Uri Yaron, PhD, Johnson & Johnson
Session V: Translational Pathway for Catheter Ablation - End
SESSION VI: TRANSLATIONAL PATHWAY FOR VENTRICULAR ASSIST DEVICES
Session VI
Session VI: Translational Pathway for Ventricular Assist Devices
1 Topic
Session VI Topics
Ventricular Assist Devices, The Windy Road to Recovery
2 Topics
Learning Objectives
Lecture – Sr. Magdi Yacoub, MD, Aswan Heart Center, London
The Methods for Left Ventricular Assist Devices Development
2 Topics
Learning Objectives
Lecture – Francis Pagani, MD, University of Michigan
The Endpoints for Left Ventricular Assist Device Evaluation
2 Topics
Learning Objectives
Lecture – Keith Aaronson, MD, University of Michigan
Session VI: Translational Pathway for Ventricular Assist Devices - End
0% Complete
0/207 Steps
Previous Session

ISCTR Mission

Translational Pathways for Cardiovascular Devices ISCTR Mission
In Progress

Nabil Dib, MD, Msc, FACC, FESC
Professor of Medicine
Director of Cardiovascular Research, Dignity Health

Previous Session
Back to Course
Next Session